Uji klinis Kejang di New York
16 studi untuk Kejang mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- NYU Comprehensive Epilepsy Center - BRANY - PPDS, New York
- Weill Cornell Medicine/New York Presbyterian Hospital, New York
Menerima pesertaFase 3
Usia 2 hingga 55 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Boston Children's Health Physicians, Hawthorne
Menerima pesertaFase 1
Usia 12 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Albany Medical Center, Albany
- Dent Neurologic Institute, Amherst
- Northwell Health - Lenox Hill, New York
- dan 1 lainnya
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Montefiore Medical Center, The Bronx
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07563881Modulating Movement Intention Via Cortical Stimulation
- New York University School of Medicine, New York
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT03233399Prospective Natural History Study of POLG Disease
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07775872SeizEAR Safety Study
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07088835Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Lenox Hill Hospital, New York
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07594119Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Hofstra Northwell Comprehensive Epilepsy Center, Great Neck
- NYU Langone Comprehensive Epilepsy Center, New York
- SUNY Upstate Medical University, Syracuse
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091Risk Factors for Sudden Unexplained Death in Epilepsy
- NYU Comprehensive Epilepsy Center, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT01662453Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- VA NY Harbor Healthcare System, New York, NY, New York
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Apr 2026 · NCT04419272Telephone-Based Support Programs for People With Epilepsy
- NYU Langone Health, New York
Menerima peserta
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT05082181A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
- NYU Langone Comprehensive Epilepsy Center, New York
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07219407Longitudinal Study of Neurogenetic Disorders
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 27 Okt 2025 · NCT03492060Pediatric Dose Optimization for Seizures in Emergency Medical Services
- University at Buffalo, Buffalo
Menerima pesertaFase 3
6 Months – 13 Years · Semua jenis kelamin · Diperbarui 30 Sep 2025 · NCT05121324An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Middletown
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Apr 2025 · NCT06908356Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.